Richard S. Casten's most recent trade in Baudax Bio Inc was a trade of 50,000 Common Stock done at an average price of $0.5 . Disclosure was reported to the exchange on Aug. 20, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Baudax Bio Inc | Richard S. Casten | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.51 per share. | 20 Aug 2021 | 50,000 | 200,000 (2%) | 0% | 0.5 | 25,500 | Common Stock |
| Baudax Bio Inc | Richard S. Casten | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.79 per share. | 14 May 2021 | 25,000 | 150,000 (1%) | 0% | 0.8 | 19,748 | Common Stock |
| Baudax Bio Inc | Richard S. Casten | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.41 per share. | 15 Mar 2021 | 25,000 | 125,000 (1%) | 0% | 1.4 | 35,180 | Common Stock |
| Baudax Bio Inc | Richard S. Casten | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 255,000 | 255,000 | - | - | Stock Option (right to buy) | |
| Baudax Bio Inc | Richard S. Casten | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 85,000 | 100,000 (1%) | 0% | 0 | Common Stock | |
| Baudax Bio Inc | Richard S. Casten | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Baudax Bio Inc | Richard S. Casten | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 15,000 | 15,000 (0%) | 0% | 0 | Common Stock |